BioSpace News Archive

Experienced senior leader brings blend of strategic and operational skills to support company’s continued growth

A massive number of recent studies have been published by several highly concepted scientific journals, and are available at the U.S National Library of Medicine National Institutes of Health.

Cutting Edge Platform Enables the Detection of Changes in the Tumor Microenvironment Following Treatment with FLX475

After announcing their merger last month, medical product development firms Smithwise and Catapult rolled out their new brand, Archimedic.

Stakeholder group will channel collective action for national vector-borne disease strategy

The kidneys of patients living with systemic lupus erythematosus (SLE) are often under assault, and not all those living with the disease will respond to standard treatment.

Asceneuron, an emerging leader in the development of orally bioavailable modulators of tau for the treatment of neurodegenerative diseases, today announces the appointment of Dr Eric Yuen to its Board of Directors.

Micronic widens the range of successful “hybrid” tubes. The leader in sample storage introduced 4 coding concepts, a tube with multiple sample identification methods, last year.

Mogrify Ltd (Mogrify), a UK company aiming to transform the future development of cell therapies, today announced that it has moved to the Bio-Innovation Centre at the Cambridge Science Park, following the appointment of 15 new staff to its scientific and management teams including, Dr. Karin Schmitt as Chief Business Officer and Joe Foster as Chief Operating Officer.

Rinri Therapeutics, a biotechnology company developing a novel cell-based therapy to restore hearing, announced today that it successfully secured £1.4 million in seed funding.